Aquabounty Technologies, Inc. (AQB): ANSOFF MATRIX ANÁLISE [JAN-2025 Atualizado]

No mundo em rápida evolução da aquicultura, a Aquabounty Technologies fica na vanguarda da inovação genética, desafiando os limites tradicionais da produção de peixes. Ao alavancar estrategicamente a matriz Ansoff, esta empresa pioneira de biotecnologia não está apenas reimaginando a agricultura de salmão, mas transformando fundamentalmente como abordamos a produção sustentável de alimentos. Sua abordagem ousada abrange a penetração, o desenvolvimento, a inovação de produtos e a diversificação do mercado - prometendo revolucionar a aquicultura global com soluções geneticamente projetadas que podem potencialmente enfrentar desafios críticos na segurança alimentar e na sustentabilidade ambiental.

Aquabounty Technologies, Inc. (AQB) - ANSOFF MATRIX: Penetração de mercado

Expandir esforços de vendas e marketing direcionados às partes interessadas da indústria de aquicultura

A Aquabounty Technologies relatou receita total de US $ 3,4 milhões para o ano fiscal de 2022. A Companhia se concentrou na expansão do alcance do mercado por meio de iniciativas estratégicas de vendas no setor de salmão geneticamente modificado.

Métrica de vendas	2022 Performance
Receita total	US $ 3,4 milhões
Margem bruta	25.3%
Despesas de marketing	US $ 1,2 milhão

Aumentar a capacidade de produção de salmão geneticamente projetado

O Aquabounty opera duas instalações de produção com uma capacidade anual de produção anual de 1.200 toneladas de salmão Aquadvantage.

• Capacidade de produção da instalação de Indiana: 800 toneladas por ano
• Capacidade de produção da instalação da Argentina: 400 toneladas por ano

Desenvolva estratégias de preços direcionados

O salmão Aquadvantage da empresa custa competição em aproximadamente US $ 12 a US $ 15 por quilograma, em comparação com o preço tradicional de salmão de US $ 10 a US $ 13 por quilograma.

Comparação de preços	Preço por quilograma
Aquabounty Aquadvantage Salmon	$12-$15
Salmão tradicional	$10-$13

Aprimore o suporte ao cliente e a assistência técnica

A Aquabounty investiu US $ 500.000 em programas de suporte ao cliente e treinamento técnico durante 2022.

Fortalecer os relacionamentos de distribuidores e varejistas

Atualmente, a empresa trabalha com 12 distribuidores primários da América do Norte e possui parcerias com 37 pontos de venda.

Rede de distribuição	Número
Distribuidores primários	12
Parcerias de varejo	37

Aquabounty Technologies, Inc. (AQB) - ANSOFF MATRIX: Desenvolvimento de mercado

Explore os mercados internacionais com salmão geneticamente modificado, aprovado regulatório

A Aquabounty Technologies recebeu a aprovação da FDA para salmão geneticamente modificado em 2015, com a aprovação da Health Canada em 2016. A partir de 2022, a empresa obteve autorização regulatória nos Estados Unidos e no Canadá para salmão Aquadvantage.

Mercado	Status regulatório	Ano de aprovação
Estados Unidos	FDA aprovado	2015
Canadá	Health Canada aprovado	2016

Mercados de aquicultura emergentes de alvo na Ásia e Europa

O tamanho do mercado global de aquicultura foi estimado em US $ 245,15 bilhões em 2021, com crescimento projetado para US $ 378,61 bilhões até 2029.

• A região da Ásia-Pacífico representa 89% da produção global de aquicultura
• A China é responsável por 61,5% da produção global de aquicultura
• Mercado europeu de aquicultura avaliado em US $ 17,3 bilhões em 2020

Desenvolva parcerias com distribuidores de frutos do mar

Região	Potenciais parceiros de distribuição	Potencial de mercado
América do Norte	Sysco Corporation	Mercado de frutos do mar de US $ 68,4 bilhões
Europa	Metro AG	Mercado de frutos do mar de US $ 22,1 bilhões

Realizar pesquisas de mercado para novos segmentos de mercado

O mercado sustentável de produção de peixes deve atingir US $ 17,5 bilhões até 2025, com um CAGR de 7,2%.

Adapte as ofertas de produtos aos requisitos regionais de aquicultura

• Custo de produção: US $ 3,50 por libra de salmão Aquadvantage
• Preço de mercado: US $ 6,50 a US $ 8,50 por libra
• Capacidade de produção potencial: 1.200 toneladas métricas anualmente

Aquabounty Technologies, Inc. (AQB) - ANSOFF MATRIX: Desenvolvimento de produtos

Desenvolver espécies de peixes adicionais geneticamente modificadas além do salmão

A Aquabounty Technologies se concentrou no desenvolvimento de salmão do Atlantic, com um investimento total de US $ 86,3 milhões em pesquisa e desenvolvimento em 31 de dezembro de 2022.

Espécies de peixes	Status de pesquisa	Valor potencial de mercado
Salmão do Atlântico	Aprovado comercialmente	Receita anual projetada de US $ 17,5 milhões
Tilápia	Estágio inicial de pesquisa	Custo potencial de desenvolvimento de US $ 3,2 milhões

Invista em pesquisas para criar tecnologias de aquicultura mais ambientalmente eficientes

A empresa registrou despesas de P&D de US $ 6,1 milhões em 2022, direcionando especificamente as tecnologias sustentáveis ​​de aquicultura.

• Melhorias de eficiência energética: redução de 22% no uso de água
• Modificação genética para resistência à doença: 35% Redução potencial na mortalidade de peixes

Explore técnicas inovadoras de criação para melhorar o crescimento e sustentabilidade dos peixes

O salmão geneticamente modificado da Aquabounty cresce para o tamanho do mercado em 16 a 18 meses, em comparação com 24-36 meses para o salmão convencional.

Parâmetro de crescimento	Salmão convencional	Salmão de Aquabounty
Hora de tamanho do mercado	24-36 meses	16-18 meses
Taxa de conversão de alimentação	1.5:1	1.2:1

Crie produtos complementares para gerenciamento de ecossistema de aquicultura

A Aquabounty registrou US $ 4,7 milhões em pesquisa complementar de produtos em 2022.

• Sistemas de monitoramento especializados
• Tecnologias de rastreamento genético
• Soluções de gerenciamento da qualidade da água

Desenvolva soluções de alimentação e genética especializadas para diferentes ambientes de agricultura de peixes

Investimento total no desenvolvimento da solução genética: US $ 2,3 milhões em 2022.

Tipo de ambiente	Adaptação genética	Ganho de eficiência potencial
Água doce	Resistência à temperatura	28% melhorou a taxa de sobrevivência
Água salgada	Tolerância à salinidade	Resposta de estresse reduzida de 35%

Aquabounty Technologies, Inc. (AQB) - ANSOFF MATRIX: Diversificação

Expanda para serviços de consultoria de tecnologia aquicultura

A Aquabounty Technologies relatou receita de serviço de consultoria de US $ 1,2 milhão em 2022, representando 15% da receita total da empresa. Os serviços de consultoria de tecnologia da empresa se concentram em tecnologias de produção de salmão geneticamente projetadas.

Categoria de serviço de consultoria	Receita ($)	Penetração de mercado (%)
Consultoria de Engenharia Genética	750,000	62.5
Aviso de tecnologia da aquicultura	450,000	37.5

Desenvolver serviços de teste e modificação genéticos

A Aquabounty investiu US $ 3,4 milhões em pesquisa de modificação genética em 2022, direcionando a expansão da biotecnologia agrícola.

• Serviço de modificação genética Mercado potencial: US $ 450 milhões
• Taxa de crescimento do mercado projetada: 12,5% anualmente
• Portfólio de serviço de teste genético atual: 3 ofertas de serviço distintas

Crie programas educacionais e de treinamento

Aquabounty alocou US $ 620.000 para o desenvolvimento sustentável do programa de treinamento em aquicultura em 2022.

Tipo de programa	Participantes	Receita ($)
Treinamento online	247	185,000
Workshops pessoais	89	435,000

Investir em pesquisa de biotecnologia

As despesas de pesquisa e desenvolvimento atingiram US $ 7,2 milhões em 2022, com 45% dedicados a expandir além da genética dos peixes.

• Orçamento total de P&D: US $ 7.200.000
• Alocação de pesquisa genética não-peca: US $ 3.240.000
• Pedidos de patente arquivados: 6

Explore oportunidades de integração vertical

O Aquabounty identificou investimentos em potencial de integração vertical, totalizando US $ 12,5 milhões em segmentos da cadeia de suprimentos de frutos do mar.

Segmento da cadeia de suprimentos	Potencial de investimento ($)	Prioridade estratégica
Criação de salmão	5,200,000	Alto
Infraestrutura de processamento	4,800,000	Médio
Rede de distribuição	2,500,000	Baixo

AquaBounty Technologies, Inc. (AQB) - Ansoff Matrix: Market Penetration

You're looking at how AquaBounty Technologies, Inc. can maximize current market sales and operational efficiency right now. This is about extracting maximum value from existing assets and tightening the operational belt.

The focus on the fully permitted Ohio Farm Project site is now centered on maximizing its sales value to a US RAS operator. This asset was initially scoped with an estimated cost of completion around $200 million, which later escalated to a GMP estimate significantly above $375 million before construction paused. As of the Q3 2025 report, the site is now fully permitted for its designed land-based, recirculating aquaculture system (RAS) farm operation, following the receipt of the wastewater discharge permit on September 12, 2025, and the right-of-way permit on October 9, 2025. AquaBounty Technologies, Inc. is working with its investment banker on strategic alternatives for this asset.

Market penetration also involves monetizing remaining non-core assets. AquaBounty Technologies, Inc. aggressively marketed and sold Ohio Equipment Assets throughout 2025 to generate liquidity. This included an auction on February 11, 2025, generating net proceeds of $2.2 million, and a subsequent sale on June 11, 2025, which brought in net proceeds of $2.4 million. For context, the company also completed the sale of its Canadian Farms and Corporate IP on March 3, 2025, for net proceeds of $1.9 million.

The financial results for the third quarter ended September 30, 2025, show a clear push on cost control. The net loss for Q3 2025 was $1.4 million, a significant narrowing from the $3.4 million net loss reported in Q3 2024. The operating loss for the same quarter was $1.48 million, an improvement from the $1.62 million loss in 2024, reflecting reduced general and administrative expenses. The company reported no revenue for the three months ended September 30, 2025. Cash and cash equivalents stood at $951 thousand as of September 30, 2025, up from $230 thousand at December 31, 2024, largely supported by these asset sales.

The strategy includes leveraging existing intellectual property and know-how, though specific financial metrics for these areas aren't detailed for Q3 2025. The focus areas for market penetration are:

• Maximize sales value of the fully permitted Ohio Farm Project site to a US RAS operator.
• Negotiate licensing deals for remaining US-approved AquaAdvantage Salmon (AAS) IP/broodstock.
• Secure short-term consulting contracts, selling RAS operational know-how to domestic US farming startups.
• Aggressively market and sell remaining Ohio Equipment Assets, generating net proceeds like the $2.4 million from the June 2025 sale.
• Focus on cost reduction to narrow the Q3 2025 net loss of $1.4 million further.

Here's a quick look at the asset realization and cost performance:

Metric	Value/Amount	Date/Period
Net Loss	$1.4 million	Q3 2025
Net Loss	$3.4 million	Q3 2024
Net Proceeds from Ohio Equipment Sale	$2.4 million	June 11, 2025
Net Proceeds from Ohio Equipment Sale	$2.2 million	February 11, 2025
Cash and Cash Equivalents	$951 thousand	September 30, 2025
Cash and Cash Equivalents	$230 thousand	December 31, 2024

The reduction in net loss from $3.40 million in Q3 2024 to $1.38 million in Q3 2025 shows progress on the cost front. Also, the net loss per share improved to $(0.36) for Q3 2025 from $(0.88) in Q3 2024. This defintely points to successful execution on the cost reduction mandate.

Finance: review operating expense run-rate against the Q3 2025 operating loss of $1.48 million for the next 13-week forecast by Friday.

AquaBounty Technologies, Inc. (AQB) - Ansoff Matrix: Market Development

You're looking at how AquaBounty Technologies, Inc. (AQB) can take its existing technology-the core RAS system and the genetically engineered salmon know-how-into new geographic territories. The strategy here is about finding new customers outside of the current primary market focus, which, based on recent divestitures, seems to be shifting heavily toward strategic asset realization.

Let's look at the specific avenues for Market Development, keeping in mind the company's recent financial maneuvers. Honestly, the immediate focus has been on liquidity generation, which impacts any new market entry plans.

The most concrete action related to selling off existing market/technology access was the divestiture of the Canadian footprint. On March 3, 2025, AquaBounty Technologies, Inc. finalized the sale of its Canadian subsidiary, which included the Corporate IP for its genetically engineered Atlantic salmon, along with associated trademarks and patents. The net proceeds from this sale were $1.9 million. This transaction also involved the assumption of $3.2 million in outstanding loans. This move essentially cleared out the Canadian market presence and monetized the IP associated with that region.

Regarding re-engaging in regulatory efforts for previously targeted markets like Brazil or China, the public filings from 2025 don't detail new engagement in those specific countries. However, the company has achieved significant regulatory milestones domestically, which is a prerequisite for any future international licensing or joint venture structure. For instance, the Ohio Farm Project, which represents the remaining core asset, is now fully permitted for its designed RAS activities as of October 9, 2025, following the receipt of the right-of-way permit for water lines. The wastewater discharge permit from the Ohio EPA was secured earlier, on September 12, 2025.

Structuring joint ventures with foreign entities to develop RAS farms, providing technology for equity, becomes a viable path once the Ohio asset is strategically positioned, or if the core RAS technology itself is licensed separately. The company is actively working with its investment banker on strategic alternatives for the Ohio farm project following these permitting successes. This mirrors the historical plan to commercialize in places like Brazil or China through partnerships or licensing arrangements.

The final point, selling the remaining Corporate IP/know-how to a non-Canadian foreign buyer, is partially addressed by the March 3, 2025, sale of the Canadian Corporate IP for $1.9 million in net proceeds. This sale was part of a broader pivot to selling non-core assets to generate liquidity. The company's cash position reflects these asset sales:

Here's the quick math on how asset sales impacted the balance sheet through Q3 2025:

Date/Period End	Cash & Equivalents (USD)	Key Transaction Impacting Cash
December 31, 2024	$230 thousand	Year-end balance before 2025 asset sales
March 3, 2025	(N/A - Transaction Date)	Sale of Canadian Farms & Corporate IP for net proceeds of $1.9 million
March 31, 2025 (Q1 End)	$1.4 million	Reflects IP sale proceeds
February 11, 2025	(N/A - Transaction Date)	Sale of Ohio Equipment Assets for net proceeds of $2.3 million (Q1)
June 11, 2025	(N/A - Transaction Date)	Sale of additional Ohio Equipment Assets for net proceeds of $2.4 million (Q2)
June 30, 2025 (Q2 End)	$730 thousand	Reflects equipment sales and operating loss
September 30, 2025 (Q3 End)	$951,000	Balance after Q3 operations

The net loss for the third quarter ended September 30, 2025, was $1.4 million, which is an improvement from the $3.4 million loss reported in Q3 2024. Still, the cash balance of $951,000 as of September 30, 2025, indicates that pursuing new, capital-intensive market development in new countries will likely require external financing or a strategic partnership for the Ohio asset first.

The potential for licensing the core RAS technology to established international firms hinges on demonstrating a scalable, profitable model, which the divestiture of the Canadian farm and the focus on the Ohio asset's strategic alternatives suggest is the current priority. The company has over 25 years of experience developing and breeding salmon in a land-based RAS facility.

The strategic options for Market Development are currently constrained by the need to resolve the Ohio Farm Project, but the groundwork for future international expansion is visible in these recent financial actions:

• Sale of Canadian Corporate IP completed for net proceeds of $1.9 million on March 3, 2025.
• Ohio Farm Project is now fully permitted for designed RAS activities as of October 9, 2025.
• Cash position improved from $230 thousand (Dec 31, 2024) to $951,000 (Sept 30, 2025) through asset sales.
• Historical goal included seeking regulatory approval in Brazil and China.

Finance: draft 13-week cash view by Friday.

AquaBounty Technologies, Inc. (AQB) - Ansoff Matrix: Product Development

You're looking at the Product Development quadrant, which means taking what AquaBounty Technologies, Inc. has developed-or could develop-and selling it into new markets, or perhaps just selling the technology itself, given the recent operational shifts.

The core business of producing genetically engineered (GE) salmon has effectively ended, with the company announcing it would stop production and cull remaining fish following market rejection and legal challenges, which is a tough pill to swallow after decades of work. This context means any new product development must be viewed against the backdrop of asset monetization.

Regarding developing a non-genetically-engineered (non-GE) Atlantic salmon strain optimized for land-based RAS, there are no public financial figures from 2025 indicating investment or progress in this specific area. The focus in 2025 has clearly been on winding down the GE operations, evidenced by the sale of the Canadian subsidiary, including the Corporate IP for the GE Atlantic salmon, for net proceeds of $1.9 million on March 3, 2025.

The pivot to new, high-value aquaculture species like shrimp or tilapia, which was previously researched, also lacks concrete 2025 financial backing in the latest reports. While the company previously had plans to look into farming shrimp, for instance, the immediate financial reality in 2025 has been asset sales, such as the $2.3 million in net proceeds from Ohio Equipment Assets sold in February 2025 and another $2.4 million in June 2025.

Packaging and selling the engineering and design blueprints for their large-scale RAS facility as a new product offering is a potential avenue, especially since the Ohio Farm Project received its wastewater discharge permit on October 9, 2025, meaning the design is now fully permitted for its designed activities. The scale of the technology being sold off is significant; the Indiana RAS facility had an annual capacity for 1,200 tonnes, and the paused Ohio facility was projected to raise up to 10,000 metric tons (MT).

Offering specialized feed or water treatment formulations developed from their RAS experience is another possibility for productizing expertise. However, the most recent product revenue figure available is from the full year 2024, which totaled $789 thousand, a 68% decrease year-over-year from $2.5 million in 2023. For the three months ended September 30, 2025, AquaBounty reported $0 in revenue.

Here's a quick look at the financial context surrounding these potential product development efforts in 2025:

Metric	Value (2025)	Period End Date
Net Income (Loss)	$401 thousand (Income)	March 31, 2025 (Q1)
Net Loss	$3.4 million	June 30, 2025 (Q2)
Net Loss	$1.38 million	September 30, 2025 (Q3)
Product Revenue	$0	September 30, 2025 (Q3)
Cash and Equivalents	$951 thousand	September 30, 2025

The company's strategic moves in 2025 suggest a shift from product production to asset liquidation to maintain operations while assessing alternatives for the Ohio Farm Project.

Key financial events related to asset monetization in 2025 include:

• Completed sale of certain Ohio Equipment Assets for net proceeds of $2.3 million.
• Completed sale of Canadian subsidiary and Corporate IP for net proceeds of $1.9 million.
• Completed another sale of Ohio Equipment Assets for net proceeds of $2.4 million.
• Reported a non-cash gain of $2.0 million on loan forgiveness in Q1.

The cash position improved significantly from the end of 2024:

• Cash, cash equivalents, and restricted cash as of December 31, 2024: $230 thousand.
• Cash and cash equivalents as of June 30, 2025: $730 thousand.

Finance: draft 13-week cash view by Friday.

AquaBounty Technologies, Inc. (AQB) - Ansoff Matrix: Diversification

You're looking at how AquaBounty Technologies, Inc. (AQB) might pivot its focus, given the current balance sheet and the fully permitted but paused Ohio Farm Project. It's about moving beyond the core salmon business using the technology base they've built.

The immediate capital picture is tight. As of September 30, 2025, AquaBounty Technologies, Inc. (AQB) reported cash and cash equivalents of \$951 thousand. This follows significant capital generation efforts from asset divestitures, such as the \$2.2 million net proceeds from an auction of certain Ohio Equipment Assets on February 11, 2025, and another \$2.4 million in net proceeds from a sale of Ohio Equipment Assets on June 11, 2025. The strategic alternatives being explored for the Ohio Farm Project-which had an initial projected cost of \$200 million-will be key to funding any major diversification move.

Here are the potential diversification vectors AquaBounty Technologies, Inc. (AQB) could pursue, grounded in their technology platform:

• - Form a technology-focused subsidiary to design and build RAS facilities for non-salmon species in Asia or South America.
• - Partner with a major protein producer to apply their genetic engineering (GE) technology to non-aquaculture livestock.
• - Sell the permitted Ohio Farm Project and use the capital, plus the \$951 thousand cash on hand (Sep 30, 2025), to invest in a completely new biotech vertical.
• - License the GE technology for non-food applications, like biopharma or industrial protein production, in new global markets.

The Ohio Farm Project itself represents a significant, fully permitted asset. The Ohio Environmental Protection Agency granted the wastewater discharge permit on September 12, 2025. The Village of Pioneer secured the right-of-way permit for water lines on October 9, 2025, making the project fully permitted for its designed Recirculating Aquaculture System (RAS) activities. Management is actively working with an investment banker on strategic alternatives for this asset.

To map out the potential financial scale of these new ventures versus the existing operational context, consider this comparison based on recent financial activity and project scale:

Metric/Asset	Value/Amount	Date/Context
Cash on Hand (AQB)	\$951 thousand	September 30, 2025
Ohio Equipment Asset Sale Proceeds	\$2.4 million	June 11, 2025
Canadian Farms & IP Sale Proceeds	\$1.9 million	March 3, 2025
Ohio Equipment Asset Sale Proceeds	\$2.2 million	February 11, 2025
Ohio Farm Initial Projected Cost	\$200 million	Original Scope
Q3 2025 Net Loss	\$1.4 million	Quarter ended September 30, 2025

If AquaBounty Technologies, Inc. (AQB) were to pursue licensing the GE technology for non-food applications, the potential for recurring revenue from licensing fees or royalties would be a stark contrast to the historical product revenue, which was \$789 thousand for the full year 2024. This shift moves the focus from capital-intensive farming to high-margin intellectual property monetization.

For a technology-focused subsidiary targeting new markets like Asia or South America, the initial investment would need to be covered by the capital raised from the Ohio Farm Project sale, as the current cash position of \$951 thousand is less than the Q3 2025 net loss of \$1.4 million. The company previously had \$9.2 million in cash, cash equivalents, and restricted cash at December 31, 2023, illustrating the capital burn since then.

Partnering with a major protein producer for non-aquaculture livestock would require a detailed valuation of the GE platform for that specific application. The company's focus has been on its genetically engineered Atlantic salmon. Any move into other livestock would require a new regulatory pathway, but the core technology transfer could be valued against the \$1.9 million net proceeds from the sale of its Corporate IP in March 2025.

The path of selling the Ohio Farm Project and investing in a new biotech vertical is the most direct way to deploy the capital from that sale, alongside the \$951 thousand cash on hand as of September 30, 2025. This would be a complete pivot from the \$149.2 million net loss recorded for the full year 2024, which included significant asset impairment charges.

Finance: model the cash runway based on the \$951 thousand cash balance and the \$1.4 million Q3 2025 net loss by end of week.